InsiderClue
Stocks · Health care · Biological Products, (No Diagnostic Substances)

Biogen

BIIB Clue Score50
United States Fiscal year ends December CIK 0000875045 Results filed 28 Oct 2026
Add to watchlist

What the insiders did Net buying

Individual transactions

20
Insider
Date
Role
Action
Shares
Price
Amount
Priya Singhal
28 Mar 2023
Head of Development
Sell
568
$270.06
$153.39K
Ginger Gregory
14 Nov 2022
EVP, Human Resources
Sell
5,610
$300.11
$1.68M
Susan H Alexander
27 Oct 2022
EVP Chief Legal Off & Corp Sec
Sell
5,532
$280.70
$1.55M
Chirfi Guindo
7 Jun 2021
Head of Glob Prod Strat & Com
Sell
3,087
$440.00
$1.36M
Alfred Sandrock
7 Jun 2021
Head of Research & Development
Sell
7,672
$440.00
$3.38M
Brian S Posner
4 Jun 2021
Director
Sell
360
$274.17
$98.70K
Alfred Sandrock
4 Nov 2020
EVP, Research & Development
Sell
1,500
$350.00
$525.00K
Brian S Posner
2 Dec 2019
Director
Sell
1,055
$292.35
$308.43K
Michael D Ehlers
26 Sep 2018
EVP, Research and Development
Sell
1,000
$350.00
$350.00K
Alfred Sandrock
27 Feb 2018
EVP, Chief Medical Officer
Sell
259
$290.83
$75.32K
Alfred Sandrock
20 Feb 2018
EVP, Chief Medical Officer
Sell
743
$292.00
$216.96K
Alfred Sandrock
15 Feb 2018
EVP, Chief Medical Officer
Sell
1,294
$298.85
$386.71K
Susan H Alexander
25 Jul 2017
EVP Chief Legal Corp Svc & Sec
Sell
4,974
$290.01
$1.44M
Susan H Alexander
19 Jul 2017
EVP Chief Legal Corp Svc & Sec
Sell
7,758
$285.00
$2.21M
Brian S Posner
9 Jun 2017
Director
Sell
1,084
$256.31
$277.84K
Paul J Clancy
25 Apr 2017
Executive VP and CFO
Sell
9,892
$290.00
$2.87M
Alfred Sandrock
3 Apr 2017
EVP CMO Neuro & Neurodegenerat
Sell
1,981
$274.08
$542.95K
Paul J Clancy
13 Mar 2017
Executive VP and CFO
Sell
9,891
$291.55
$2.88M
Alfred Sandrock
1 Mar 2017
EVP CMO Neuro & Neurodegenerat
Sell
973
$290.07
$282.24K
Adriana Karaboutis
1 Dec 2016
EVP, Tech, Bus. Sol & Corp Aff
Sell
48
$296.53
$14.23K
Show all 73 transactions →

What was left out

Form 4 filings counted 436
Amendments (4/A) skipped 1
Filings about a different issuer 9
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 19
Sales straight out of an exercise 7
Sales at will 20
Transactions with no price 0
Shares from compensation/vesting 939,117
Sales filed before the plan box existed 19
History held since 3 Oct 2006